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eratins 8 and 18 (K8/18) heteropolymers may regulate
cell signaling via the known K18 association with 14-
3-3 proteins and 14-3-3 association with Raf-1 kinase.
We characterized Raf–keratin–14-3-3 associations and show
that Raf associates directly with K8, independent of Raf
kinase activity or Ras–Raf interaction, and that K18 is a Raf
physiologic substrate. Raf activation during oxidative and
toxin exposure in cultured cells and animals disrupt keratin–
Raf association in a phosphorylation-dependent manner.
K
 
Mutational analysis showed that 14-3-3 residues that are
essential for Raf binding also regulate 14-3-3–keratin asso-
ciation. Similarly, Raf phosphorylation sites that are important
for binding to 14-3-3 are also essential for Raf binding to
K8/18. Therefore, keratins may modulate some aspects of
Raf signaling under basal conditions via sequestration by
K8, akin to Raf–14-3-3 binding. Keratin-bound Raf kinase is
released upon Raf hyperphosphorylation and activation
during oxidative and other stresses.
 
Introduction
 
Keratins are intermediate filament proteins that are specifi-
cally expressed in epithelial cells, and consist of noncovalent
obligate associations of one or more type I (K9-20) and type
II (K1-8) keratins in an epithelial-specific manner (Moll et
al., 1982; Fuchs and Weber, 1994; Coulombe and Omary,
2002). Glandular or “simple-type” epithelial cells express
preferentially the keratin pair K8/18, as cytoplasmic fila-
mentous/oligomeric or soluble tetrameric heteropolymers
that consist of two K8 and two K18 molecules (Quinlan et
al., 1984; Omary et al., 1998). The best-characterized keratin
function is to protect epithelial cells from necrotic or apop-
totic forms of injury that are induced by mechanical and
nonmechanical stresses (Gilbert et al., 2001; Coulombe and
Omary, 2002; Oshima, 2002). This function is supported
by numerous animal model studies and by the phenotypes
of several keratin mutation-associated human diseases
(Fuchs and Cleveland, 1998; Irvine and McLean, 1999;
Magin et al., 2000). The cytoprotective and other proposed
keratin functions are likely to be regulated by keratin phos-
phorylation and keratin-associated proteins (Coulombe and
Omary, 2002). For example, K18 serine-33 (S33) phosphor-
ylation regulates keratin binding to 14-3-3 proteins during
mitosis or after exposure to phosphatase inhibitors in the
context of intact tissues or cultured cells (Liao and Omary,
1996; Ku et al., 1998, 2002). The significance of keratin–
14-3-3 interaction is related to the phosphorylation-depen-
dent association of 14-3-3 proteins with a wide range of sig-
naling molecules including Raf-1 kinase, the pro-apoptotic
protein Bad, and cdc25 phosphatase among others (Fu et al.,
2000; Tzivion and Avruch, 2002; Yaffe, 2002). Direct or
indirect keratin–Raf interaction is not known but given the
established associations of Raf kinase with 14-3-3 proteins
and K8/18 with 14-3-3 proteins, we sought to define the
dynamics, significance, and molecular domains that define
Raf–keratin–14-3-3 associations.
 
Results and discussion
 
We examined the interrelationship of the known keratin–
14-3-3 association (Liao and Omary, 1996; Ku et al., 1998)
with the potential for a keratin–Raf association, in human
colonic HT29 cells, given the established Raf–14-3-3 inter-
action (Tzivion et al., 1998). K8/18/19 immunoprecipitates
were obtained from cells, with or without pretreatment with
the phosphatase inhibitor okadaic acid (OA), followed by
immunoblotting with antibodies (Abs) to Raf or 14-3-3 pro-
teins. 14-3-3 binding to K8/18 increased dramatically due
to K18 S33 hyperphosphorylation (Ku et al., 1998), but
surprisingly Raf kinase associated with K8/18 under basal
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conditions and this association was abolished by phos-
phatase inhibition (Fig. 1 A, lanes 1 and 2). Raf–keratin as-
sociation was also noted using other antikeratin Abs (anti-
K19; Fig. 1 B), thereby indicating that it is unrelated to
cross-reaction of antikeratin Abs with Raf. The keratin–Raf
interaction was also abolished in mice upon intraperitoneal
administration of the phosphatase inhibitor and hepatotoxin
microcystin-LR (MLR; Fig. 1 A, lanes 3–6).
To distinguish between Raf binding to K8 versus K18 or
K19, we transfected BHK cells (which lack keratins) with
Raf, K8/18, K8/19, Raf
 
 
 
K8/18, or Raf
 
 
 
K8/19 followed
by immunoprecipitation of K8/18 or K8/19. As shown in
Fig. 1 B, transfected human Raf associates specifically with
K8/18 or K8/19 (lanes 4 and 8), thereby indicating that K8
is necessary for keratin–Raf binding. Endogenous hamster
Raf does not bind efficiently to the overexpressed keratins
(Fig. 1 B, lanes 3 and 7). In vitro overlay assay confirmed
that Raf interacts with K8, but not K18 (Fig. 1 C). Because
hsp70 also associates with K8, we asked whether hsp70 is
necessary for keratin–Raf association by taking advantage of
hsp70 release from K8/18 in the presence of Mg-ATP (Liao
et al., 1995). Dissociation of hsp70 from K8/18 precipitates
Figure 1. Keratin association with Raf-1 kinase. (A) HT29 cells (lanes 1 and 2) were cultured in the presence or absence of OA (1  g/ml, 2 h), 
then solubilized with 1% NP-40. Alternatively, transgenic mice (lanes 3–6) that overexpress human K18 (Ku et al., 2002) were injected with 
MLR (30  g/kg) in saline ( ) or with saline alone ( ). After 2 h, the livers were homogenized with 1% NP-40. K8/18 immunoprecipitates 
were obtained from HT29 and liver NP-40 lysates then separated by SDS-PAGE. Duplicate gels were stained with Coomassie blue or trans-
ferred then blotted with Ab to Raf or 14-3-3. Note heat shock protein 70 (hsp70) association with K8/18. (B) BHK cells were transfected with 
vector alone, Raf, K8/18, K8/19, Raf K8/18, or Raf K8/19 constructs. After 3 d, transfected cells were solubilized followed by precipitation 
of K8/18 or K8/19 using K18- or K19-specific mAb. Immunoprecipitates (i.p.) were analyzed as in A. Arrow positioned between K18 and K19 
highlights a nonspecific band, and arrowheads indicate previously characterized K18 fragments (Ku et al., 1997). (C) A total cell lysate and 
K8/18 precipitates were prepared from HT29 cells. After separation by SDS-PAGE, duplicate gels were stained with Coomassie blue (lanes 1 
and 2) or transferred to a membrane for overlay assay (lanes 1  and 2 ). The membrane was incubated with recombinant Raf kinase, washed, 
and blotted with anti-Raf Ab (lanes 1  and 2 ). (D) K8/18 precipitates were prepared from HT29 cells then incubated (30 min, 22 C) in the 
absence or presence of Mg-ATP, followed by washing then blotting with Ab to Raf or hsp70. (E) HT29 cells were incubated in the presence or 
absence of H2O2 for 1 h followed by processing 80% of the cells for K8/18 precipitation and the remaining to prepare a total cell lysate. 
Precipitates were analyzed by blotting with the indicated Ab, including phospho-Erk1/2 as an indicator of Raf kinase activity. 
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leaves keratin-bound Raf intact (Fig. 1 D). Keratin–Raf dis-
sociation also occurs upon exposure to oxidative stress, in as-
sociation with: (a) increased K18 S33 phosphorylation; (b)
keratin–14-3-3 binding; and (c) Raf kinase activation as de-
termined by Erk1/2 phosphorylation (Fig. 1 E). Together,
these results demonstrate keratin–Raf association, in a phos-
phorylation modulated and K8 dependent but hsp70 inde-
pendent fashion, in cultured HT29 cells and mouse liver.
Given the keratin–Raf association, we asked if K8/18 is
phosphorylated by Raf kinase. Recombinant human Raf-1
preferentially phosphorylated K18 (Fig. 2 A). Peptide map-
ping of the tryptic K18 phosphopeptides (Fig. 2 B), ob-
tained after in vitro phosphorylation by Raf kinase, showed
a nearly identical pattern to previously described physiologic
K18 phosphorylation (Ku et al., 1998) at S33 (peptide 1)
and S52 (peptide 2; Fig. 2 B). This was confirmed by in
vitro phosphorylation of K8/18 immunoprecipitates ob-
tained from BHK cells, cotransfected with wild-type (WT)
K8 and WT or phosphorylation mutant K18. Mutation of
K18 S52 abolishes in vitro phosphorylation of K18 by Raf
kinase, whereas mutation of K18 S33 does not have a signif-
icant effect on overall K18 phosphorylation since its phos-
phorylation (i.e., Fig. 2 B, peptide 1) is relatively minor (Fig.
2 C). The K18 phosphorylation mutants were confirmed us-
ing pS52/pS33-specific Abs (Fig. 2 C). In vivo K18 phos-
phorylation by Raf was verified by comparing K18 S33 and
S52 phosphorylation in BHK cells cotransfected with WT
K8/18 and WT Raf kinase or the kinase-inactive Raf S259/
S621A double mutant. Under these conditions, K18 S33/
S52 phosphorylation increased in BHK cells that were trans-
fected with WT Raf, but not Raf S259/S621A or vector
(Fig. 2 D). This supports the in vitro kinase assay data and
indicates that Raf is a likely physiologic K18 kinase that
phosphorylates K18 primarily at S52
 
 
 
S33. Given the obli-
gate and heteropolymeric noncovalent association of K8 and
K18 in cells, the combined results of Figs. 1 and 2 suggest
that K8 serves as an adaptor for Raf kinase, which in turn
phosphorylates K18.
The observation that phosphatase inhibition dissociates
keratin–Raf binding (Fig. 1 A), led us to test if keratin or
Raf hyperphosphorylation, or both, cause release of the kera-
tin–Raf complex. Reconstitution of in vitro–translated Raf
kinase binding to K8/18 immunoprecipitates that were iso-
lated from OA-treated or untreated HT29 cells was similar
(Fig. S1, A and B, available at http://www.jcb.org/cgi/con-
tent/full/jcb.200402051/DC1). K18 S33/S52-to-Ala or K8
S23/S73/S431-to-Ala mutations (which abolish all known
and major K8/18 phosphorylation sites) do not affect kera-
tin–Raf binding as determined by cotransfection into BHK
cells (Fig. S1 C). These keratin mutants behave similar to
WT K8/18 in that they also release bound Raf in the cells
treated with OA (not depicted). Hence, modulation of Raf,
rather than K8, phosphorylation is likely to be responsible
for dissociating the keratin–Raf complex.
The role of Raf phosphorylation was confirmed by
cotransfection, into BHK cells, of K8/18 and a series of Ser-
to-Ala single or double Raf mutants that inhibit known
phosphorylation sites (S259/S621/S338/Y341/T491/S494).
Figure 2. Raf kinase phosphorylation 
of K18 in vitro and in vivo. (A) K8/18 
precipitates were obtained from HT29 
cells then heated to inactivate any 
bound kinases. The precipitates were 
incubated with  -[
32P]ATP (lanes 1 and 3) 
or  -[
32P]ATP Raf kinase (lanes 2 and 4) 
for 10 min, quenched with sample buffer, 
and analyzed by SDS-PAGE, Coomassie 
staining, and autoradiography. (B) A 
duplicate of the 
32P-labeled K18 band 
shown in A (lane 4) was isolated, 
digested with trypsin and analyzed by 
peptide mapping. x, origin of sample 
loading. Spots 1 and 2 represent K18 
phosphopeptides containing S33 (Ku et 
al., 1998) and S52 (Ku and Omary, 
1994), respectively. (C) BHK cells were 
transfected with WT K8 and one of the 
indicated K18 constructs. K8/18 precipi-
tates were obtained after 3 d, followed 
by in vitro phosphorylation using Raf 
kinase as in A. Phosphorylated samples 
were analyzed by autoradiography, or 
by blotting with phosphoepitope-specific 
Ab. Arrowheads indicate degraded 
keratins. (D) BHK cells were cotransfected 
with WT K8/18 and WT or kinase-
inactive Raf. Total lysates were prepared 
then blotted with Ab to K18, Raf, or the 
indicated phosphoepitopes. Arrow indi-
cates a nonspecific band. 
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Of these, two Raf constructs partially (S621A) or greatly
(S259A/S621A) diminished keratin–Raf interaction, whereas
other mutations had minimal effects (Fig. 3 A). Both Raf
mutations resulted in deactivation of Raf kinase and hyper-
phosphorylation of Raf S338 (Fig. 3 A, lanes 5 and 6), per-
haps due to increased accessibility of Pak3 kinase to S338
after Raf S621A mutation (King et al., 1998). Raf kinase ac-
tivity was determined by increased phospho-Erk1/2 as de-
tected in cells transfected with WT Raf but not vector alone
(Fig. 3 A, lanes 1 and 2). The Raf S338A mutation causes
Raf S621 dephosphorylation and Raf kinase deactivation,
but had a minimal effect on keratin–Raf association (Fig. 3
A, lane 7). In addition, a Raf R89L mutation that disrupts
Ras–Raf binding (Fabian et al., 1994) did not affect keratin–
Raf association. We also examined Raf phosphorylation and
kinase activity in BHK cells under conditions of keratin–Raf
complex formation or release (Fig. 3 B). Release of Raf is
associated with its kinase activation (as determined by
increased phospho-Erk1/2) and increased Raf S338/S621
phosphorylation. Together, the Raf pS259/pS621 sites that
are involved in 14-3-3–Raf association (Tzivion et al., 1998)
are also important in keratin–Raf association (S621
 
 
 
S259).
Keratin–Raf association is independent of Ras–Raf interac-
tion and does not require Raf kinase activity, whereas Raf
dissociation from keratin occurs in concert with its activa-
tion. Quantitative immunoblotting indicated that 
 
 
 
2% of
the total Raf pool binds to K8/18 (unpublished data). This
fraction likely reflects mainly phosphorylated Raf.
Given that any two of the three K8/18, Raf, and 14-3-3
entities can associate with each other, we tested the dynam-
ics of their association by in vitro reconstitution. K8/18 im-
munoprecipitates (prewashed with the detergent Empigen
[Emp], which releases bound Raf and 14-3-3) were incu-
bated with Raf or 14-3-3 proteins alone, together before or
after premixing, or sequentially followed by washing then as-
sessment of the keratin bound 14-3-3 or Raf. As shown in
Fig. 4 A: (a) Raf and 14-3-3 binding to keratins can be re-
constituted (lanes 3 and 4); (b) keratin-bound Raf blocks
14-3-3 binding but not vice versa (lanes 5 and 6); and (c)
when Raf and 14-3-3 are added simultaneously, Raf bound
to keratins preferentially though premixing yielded preferen-
tial Raf–14-3-3 binding (lanes 7 and 8). This indicates that
Raf can bind to K8/18 efficiently, even in the presence of
14-3-3 proteins, and can also block keratin–14-3-3 binding.
We then tested the effect of mutating the Raf-binding
motif of 14-3-3 on keratin–14-3-3 binding in vitro and in
vivo. The 14-3-3
 
 
 
 crystal structure suggests that positively
charged residues in its amphipathic groove, including K49/
R56/R60, modulate diverse ligand binding (Liu et al., 1995;
Xiao et al., 1995; Yaffe et al., 1997; Obsil et al., 2001). For
example, 14-3-3
 
 
 
 K49E or R56E decreased Raf–14-3-3 in-
teraction, whereas R60E had subtle effects on 14-3-3–Raf
binding (Zhang et al., 1997). As shown in Fig. 4 B, WT pu-
rified recombinant 14-3-3
 
 
 
 but none of its mutants (K49E/
R56E/R60E) bind K8/18. Similar findings were obtained in
BHK cells transfected with WT K8/18 and WT or mutant
Figure 3. Mutational analysis of keratin–Raf association. (A) BHK cells were cotransfected with WT K8/18 and the indicated Raf constructs. 
After 3 d, total lysates and K8/18 immunoprecipitates (i.p.) were separated by SDS-PAGE and analyzed by Coomassie staining or blotted with 
the listed Ab. Arrowheads indicate degraded keratins and arrow indicates a nonspecific band. (B) BHK cells were cotransfected with WT K8/18 
and WT Raf. After 3 d, cells were cultured in the presence (to release Raf from K8/18) or absence of OA (1  g/ml, 2 h). Total lysates and K8/18 
precipitates were prepared and analyzed as in A. Arrowheads indicate degraded keratins. 
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flag-tagged 14-3-3
 
 
 
 (Fig. 4 C). This indicates that the posi-
tively charged residues (K49/R56/R60) in the Raf-binding
groove of 14-3-3
 
 
 
 are critical for binding to K8/18.
The findings of this work indicate that keratin intermediate
filaments can sequester a unique population of Raf-1 kinase
and regulate its signaling potential in a Raf kinase phosphory-
lation-dependent fashion. This is similar to 14-3-3 regulation
of Raf-1, and highlights the molecular domains and dynamic
features of keratin–14-3-3–Raf interactions. For example, Raf
S259/S621 regulates Raf interaction with 14-3-3 and K8/18
(Fig. 3), whereas 14-3-3 K49 and R56 regulate 14-3-3 interac-
tion with Raf and K8/18 (Fig. 4). Given the overlap of 14-3-3
positively charged residues that regulate binding to keratins
and to Raf kinase, our working model is phosphorylated Raf
pS259/pS621, that makes up at least 2% of the total Raf pool,
may interact with similar positively charged Arg/Lys residues
on K8 that remain to be identified (Fig. 5 A). Some differences
do distinguish keratin–14-3-3 versus Raf–14-3-3 association
including the importance of 14-3-3 R60 for keratin–14-3-3
 
Figure 4.
 
Reconstitution of keratin–Raf–14-3-3 associations, and 
effect of 14-3-3 mutation on keratin–14-3-3 binding.
 
 (A) K8/18 
precipitates were obtained from NP-40–solubilized HT29 cells and 
treated with 1% Emp to release bound Raf. Stripped K8/18 precipitates 
were incubated with recombinant 14-3-3
 
 
 
 (1 
 
 
 
g) or in vitro–translated 
 
35
 
S-Raf (alone, or sequentially, or as a mixture [with or without 
premixing]). After 30 min (22
 
 
 
C), samples were washed and analyzed 
by SDS-PAGE, Coomassie staining, blotting with the indicated Ab, 
or autoradiography. (B) K8/18 precipitates were obtained from G
 
2
 
/M 
enriched HT29 cells that were treated with colcemid (5 
 
 
 
g/ml) for 
36 h (to induce K18 S33 phosphorylation and 14-3-3 binding). 
Precipitates of 1% NP-40 lysates were treated with 1% Emp to strip 
bound 14-3-3 then incubated with 1 
 
 
 
g of recombinant WT or 
mutant 14-3-3
 
 
 
 (1 h, 4
 
 
 
C; lanes 7–10), or with NP-40 lysates of 
HT29 cells as a source of 14-3-3 (lane 11), followed by washing and 
analysis by SDS-PAGE. Input 14-3-3 proteins are shown in lanes 
1–4. (C) BHK cells were cotransfected with WT K8/18 and one of 
the flag-tagged 14-3-3
 
 
 
 constructs including triple mutant (K49/R56/
R60
 
→
 
E). After 3 d, cells were treated with OA (1 
 
 
 
g/ml, 2 h) fol-
lowed by immunoprecipitation (i.p.) of K8/18, whereas a fraction of 
the cells was used to prepare a total cell lysate. K8/18 precipitates 
and total cell lysates were blotted with an anti-Flag Ab to detect 
keratin associated 14-3-3
 
 
 
 and the level of overexpressed 14-3-3
 
 
 
, 
respectively.
Figure 5. Keratin, Raf kinase, and 14-3-3 protein interactions. (A) 
Raf pS259/pS621 associates with positively charged residues (K49/
R56/R60) on 14-3-3 and may interact with similar positively 
charged residues (K and R) on K8/18. (B) A schematic summarizing 
keratin–Raf association and release. K8/18 associates with Raf under 
basal conditions. Oxidative or toxin stress conditions cause dissoci-
ation of the keratin–Raf complex, and hyperphosphorylation of K8/
18 (P) and Raf (pS) in association with Raf activation and K18 phos-
phorylation. Activation of Raf kinase also renders Raf available to 
phosphorylate other substrates. 
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(this work) but not Raf–14-3-3 binding (Zhang et al., 1997).
Keratin-bound Raf kinase is released from K8/18 during oxi-
dative and some toxin-mediated stresses in association with its
activation and phosphorylation of K18 (Fig. 1), thereby sug-
gesting a novel mechanism for Raf-1 kinase activation (Fig. 5
B). Notably, keratin–Raf dissociation is independent of mito-
genic stimuli including exposure to EGF or mitosis (not de-
picted), which is supported by Raf–keratin binding being un-
related to Ras–Raf association (Fig. 3 A).
Our results also provide strong evidence that K18 is a
novel in vivo substrate for Raf-1 kinase (Fig. 2). Raf binding
with K8/18 is independent of Raf’s kinase activity, which is
consistent with its activation upon release from K8/18. Our
working model is that inactive Raf binds with K8 then phos-
phorylates K18 upon its activation and release from K8 (Fig.
5). We cannot exclude the possibility that keratin phosphor-
ylation by Raf-1 kinase may occur by the Raf pool that is not
keratin bound.
The only other intermediate filament protein known to
interact with 14-3-3 is vimentin, which binds to 14-3-3 after
treatment with the phosphatase inhibitor calyculin A (Tzi-
vion et al., 2000). Vimentin complexes indirectly with Raf
kinase, via unknown components, and is phosphorylated by
one or more kinase constituents of this complex but not by
Raf itself (Janosch et al., 2000). The mechanism of regula-
tion of the indirect Raf binding with vimentin has not been
tested but may be different to that of keratin–Raf associa-
tion, given the direct nature of the keratin–Raf association
described herein and the finding that Raf S259/S621 phos-
phorylation is not essential for Raf–vimentin binding (Ja-
nosch et al., 2000). The direct K8/18–Raf association, inde-
pendent of Raf–Ras binding and Raf kinase activity suggests
a new role for keratins, which may extend to other interme-
diate filament proteins, in modulating some of Raf cell sig-
naling events in epithelial cells.
 
Materials and methods
 
Cell lines and Abs
 
HT29 (human colon) and BHK-21 cells were cultured as recommended by
the supplier (American Type Culture Collection). The Abs that were used
(Ku et al., 1998) included: mAb L2A1, which recognizes human K18; rabbit
Ab 8592, which recognizes hK8/18; mAb 5B3, which recognizes hK8 phos-
pho-Ser 431 (pS431); mAb LJ4, which recognizes hK8 pS73; rabbit Ab
8250, which recognizes hK18 pS33; and rabbit Ab 3055, which recognizes
hK18 pS52. Additional Abs used were directed to: 14-3-3
 
 
 
, Raf-1, Raf
pS259, Raf pS621, and Erk (Santa Cruz Biotechnology, Inc.); mAb 4.62,
which recognizes hK19 and anti-Flag (Sigma-Aldrich); Raf pS338 (Upstate
Biotechnology); pERK (Cell Signaling). Other reagents used were: OA and
MLR (Qbiogene); Transformer™ mutagenesis kit (CLONTECH Laboratories,
Inc.); LipofectAMINE and pPROEX HT expression system (Invitrogen); TNT-
coupled transcription/translation kit (Promega); and recombinant 14-3-3
 
 
 
and recombinant hRaf-1 kinase (Upstate Biotechnology).
 
cDNA constructs and cell transfection
 
The various mutant constructs of each cDNA were generated by using the
Transformer kit as recommended by the manufacturer. BHK cells were
cotransfected with various combination of cDNA constructs for human K8,
K18, 14-3-3
 
 
 
, and Raf kinase using LipofectAMINE as recommended by
the supplier. After 3d, K8/18 immunoprecipitates were prepared as de-
scribed previously (Ku et al., 1998).
 
Biochemical methods
 
In vitro kinase assays were performed using K8/18 precipitates that were
boiled for 90 s to abolish any associated kinase activity. The precipitates
were incubated with activated Raf kinase and 
 
 
 
-[
 
32
 
P]ATP (10 min, 30
 
 
 
C).
K18 was isolated, followed by trypsin digestion and two-dimensional pep-
tide mapping (Boyle et al., 1991). For in vitro reconstitution experiments,
K8/18 immunoprecipitates were isolated from untreated or OA-treated
HT29 cells and then washed with 1% Emp in PBS to remove endogenous
keratin-associated Raf kinase. Precipitates were mixed with in vitro–trans-
lated 
 
35
 
S-Raf and/or recombinant 14-3-3
 
 
 
 (Zhang et al., 1997). In vitro–
translated 
 
35
 
S-Raf was prepared by using the TNT coupled transcription/
translation kit as recommended by the supplier. Whole cell extracts were
prepared by solubilizing with Laemmli sample buffer containing 2% SDS
followed by blotting and visualization using ECL (Ku et al., 1998). The
fraction of Raf that binds to K8 was estimated by comparison of an immu-
noblot of serially diluted total lysates run on the same gel with Raf coim-
munoprecipitated with K8/18. The overlay assay was performed as de-
scribed previously (Liao et al., 1995) except for using in vitro–translated
recombinant Raf kinase and Raf Ab.
 
Transgenic mice
 
For induction of keratin hyperphosphorylation, transgenic mice that over-
express WT human K18 (Ku et al., 2002) were intraperitoneally injected
with MLR in saline (30 
 
 
 
g/kg) or with saline alone. After 2 h, the livers
were isolated then homogenized with 1% NP-40 in PBS followed by im-
munoprecipitation using mAb L2A1. The K8/18 precipitates were sepa-
rated with SDS-PAGE then blotted with the indicated Ab.
 
Online supplemental materials
 
Fig. S1 demonstrates that keratin–Raf binding is independent of keratin
phosphorylation. Online supplemental materials is available at http://
www.jcb.org/cgi/content/full/jcb.200402051/DC1.
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